Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Chambal Fertilisers & Chemicals Ltd

CHAMBLFERT
NSE
450.55
0.46%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Chambal Fertilisers & Chemicals Ltd

CHAMBLFERT
NSE
450.55
0.46%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
18,051Cr
Close
Close Price
450.55
Industry
Industry
Fertilisers
PE
Price To Earnings
9.43
PS
Price To Sales
0.88
Revenue
Revenue
20,457Cr
Rev Gr TTM
Revenue Growth TTM
21.48%
PAT Gr TTM
PAT Growth TTM
18.47%
Peer Comparison
How does CHAMBLFERT stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
CHAMBLFERT
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
3,5995,5895,3864,3492,6434,9334,3464,9182,4495,6986,4135,898
Growth YoY
Revenue Growth YoY%
8.8-23.3-37.3-47.6-26.6-11.7-19.313.1-7.315.547.519.9
Expenses
ExpensesCr
3,4874,9564,7713,7202,4774,1813,5564,1402,2854,9375,5715,078
Operating Profit
Operating ProfitCr
111633615628167752790778163761842821
OPM
OPM%
3.111.311.414.46.315.218.215.86.713.413.113.9
Other Income
Other IncomeCr
3814901517386809586798836
Interest Expense
Interest ExpenseCr
675546363640170211
Depreciation
DepreciationCr
767778797882838382848788
PBT
PBTCr
6516581664126716786783168754842768
Tax
TaxCr
-881772002052926824924837205193182
PAT
PATCr
9433938145997448536534130549649586
Growth YoY
PAT Growth YoY%
-61.5-0.938.941.83.032.440.816.334.622.420.99.7
NPM
NPM%
2.66.17.110.63.79.112.310.95.39.610.19.9
EPS
EPS
2.38.19.211.02.511.213.413.33.313.716.214.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
9,7389,0087,5537,54110,09512,20612,71916,06927,77317,96616,64620,457
Growth
Revenue Growth%
9.3-7.5-16.1-0.233.920.94.226.372.8-35.3-7.322.9
Expenses
ExpensesCr
9,0048,2526,7776,7458,88210,30410,25613,80725,95315,92314,16317,871
Operating Profit
Operating ProfitCr
7347567767971,2121,9022,4632,2621,8192,0432,4832,587
OPM
OPM%
7.58.410.310.612.015.619.414.16.511.414.912.6
Other Income
Other IncomeCr
10549136181-2215475374225330347289
Interest Expense
Interest ExpenseCr
163266254155246503289106320173484
Depreciation
DepreciationCr
2161119285119287289300308313330341
PBT
PBTCr
4594285667378461,3282,3602,2311,4161,8872,4522,531
Tax
TaxCr
180160186245247101612665383611802617
PAT
PATCr
2802683804925991,2271,7481,5661,0341,2761,6491,914
Growth
PAT Growth%
19.2-4.342.029.421.7104.942.5-10.4-34.023.429.316.1
NPM
NPM%
2.93.05.06.55.910.113.79.83.77.19.99.4
EPS
EPS
7.15.38.712.014.229.539.837.624.930.841.247.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
414416416416416416416416416401401401
Reserves
ReservesCr
1,8371,4681,7252,1042,4783,1314,8375,9866,6526,8738,3279,438
Current Liabilities
Current LiabilitiesCr
4,1085,0084,3913,3096,5256,6781,5253,8023,1522,0371,1742,528
Non Current Liabilities
Non Current LiabilitiesCr
1,2251,3261,6253,7364,6164,4233,4853,1012,5652,2141,5211,504
Total Liabilities
Total LiabilitiesCr
7,6388,1248,0579,46313,92614,53310,24713,28912,77011,50911,40713,853
Current Assets
Current AssetsCr
4,4305,2564,8703,7736,5057,3253,1486,0755,6394,0893,6225,743
Non Current Assets
Non Current AssetsCr
3,2082,8683,1875,6907,4217,2077,0997,2147,1317,4207,7858,109
Total Assets
Total AssetsCr
7,6388,1248,0579,46313,92614,53310,24713,28912,77011,50911,40713,853

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1,064-271,2801,172-1,1308276,944-243,2393,3271,394
Investing Cash Flow
Investing Cash FlowCr
-140-339-691-1,778-1,125-455-196-119-1,873-382739
Financing Cash Flow
Financing Cash FlowCr
-937362-5005642,263-283-6,007-213-1,862-2,871-2,135
Net Cash Flow
Net Cash FlowCr
-13-489-43889740-356-49673-2
Free Cash Flow
Free Cash FlowCr
878-665400-1,250-2,3341776,709-1863,0462,720825
CFO To PAT
CFO To PAT%
380.6-9.9336.6238.3-188.867.4397.3-1.6313.3260.884.5
CFO To EBITDA
CFO To EBITDA%
145.0-3.5164.8147.1-93.243.5281.9-1.1178.0162.856.1

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,8092,2833,6026,7686,9304,4999,52317,56410,99013,70625,065
Price To Earnings
Price To Earnings
10.010.39.913.611.73.75.811.210.610.715.2
Price To Sales
Price To Sales
0.30.30.50.90.70.40.81.10.40.81.5
Price To Book
Price To Book
1.21.21.72.72.41.31.82.71.61.92.9
EV To EBITDA
EV To EBITDA
8.79.610.416.012.87.25.19.47.87.610.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
41.935.537.038.639.843.642.340.229.139.344.0
OPM
OPM%
7.58.410.310.612.015.619.414.16.511.414.9
NPM
NPM%
2.93.05.06.55.910.113.79.83.77.19.9
ROCE
ROCE%
10.310.112.110.49.414.128.821.816.622.528.3
ROE
ROE%
12.414.217.819.520.734.633.324.514.617.518.9
ROA
ROA%
3.73.34.75.24.38.417.111.88.111.114.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Chambal Fertilisers & Chemicals Ltd (CFCL) is a leading Indian manufacturer of nitrogenous fertilizers and a growing player in crop protection chemicals (CPC), specialty nutrients (SN), and sustainable agri-inputs. The company operates three urea plants at its integrated site in Gadepan, Kota (Rajasthan), with a combined annual capacity of **3.4 million metric tons (MTPA)** — approximately **12% of India’s domestic urea production**. CFCL markets a diverse portfolio under its trusted **“Uttam”** brand across 13 Indian states and one union territory, serving over 90% of the market in North, West, Central, and Southern India through a robust network of ~4,200 dealers and 60,000 retailers. --- ### **Core Business Segments** #### **1. Urea & Bulk Fertilizers** - **Stable Anchor Business:** Urea remains the company's core revenue generator, contributing consistent margins and enabling financial stability. - The company produces ~9.2 lakh MT per quarter, with all plants operating at optimal levels. Energy efficiency has improved by **2–3%** post-turnaround at Plants I and II. - In addition to urea, CFCL distributes DAP, MOP, and NPK fertilizers, with NPK sales growing significantly, particularly in southern and western states like Maharashtra, Andhra Pradesh, Telangana, and Gujarat. #### **2. Crop Protection Chemicals (CPC) & Specialty Nutrients (SN)** - A **high-growth segment**, achieving a **24% CAGR in revenue over the past three years** (INR 154 crore in FY20-21 → INR 309 crore in FY22-23). - The business saw **double-digit revenue growth in FY2024-25**, including an **80% YoY increase from new territories** and an **214% surge in CPC revenue from new geographies**. - CFCL sources formulations from third-party toll manufacturers and markets them under proprietary brands, leveraging its strong distribution and brand equity. - Currently offers **61–62 products** in herbicides, fungicides, and insecticides, with 12 new CPC/SN products launched in FY2024-25 alone. #### **3. Biologicals – A Strategic Growth Vector** - CFCL has made a major pivot toward sustainable agriculture: - Launched **UTTAM PRANAAM**, a **bio-nano phosphorus liquid fertilizer (10% P2O5)**, which sold **200,000+ bottles by Sept 2024**, and is gaining steady acceptance. - **SUPERRHIZA**, a **mycorrhizal biofertilizer**, won **“International Biological Product of the Year 2023”** from Applied Microbiology International, with **72% revenue growth in H1 FY25**. - Strong traction in the biologicals segment supports India’s **BioE3 and PM PRANAM missions**. - Plans to launch **biological fungicides and nematicides** following successful internal trials. #### **4. Entry into Seeds Business (Kharif 2025)** - CFCL is expanding into **hybrid and research-variety seeds** (targeting wheat, mustard, millet), completing a **full “seed-to-harvest” agri-input solution**. - Positioned for **integrated product bundling** and deeper farmer engagement. --- ### **Strategic Expansion & Capex Projects** #### **Technical Ammonium Nitrate (TAN) Plant – Flagship Capex Initiative** - **Project Investment:** ₹1,645 crore - **Capacity:** - **240,000 MTPA Technical Ammonium Nitrate (TAN)** - **210,000 MTPA Weak Nitric Acid (WNA)** - **Technology:** Licensed from **CASALE, Switzerland** - **Contractor:** **Larsen & Toubro Ltd** under lump-sum turnkey (LSKT) contract - **Feedstock:** Utilizes **surplus ammonia** from existing fertilizer plants (*forward integration strategy*) - **Modifications:** - Warm ammonia feed to improve efficiency - Provisions for future **Low-Density Ammonium Nitrate (LDAN)** production - **Status:** Under construction at **Gadepan, Rajasthan**; all regulatory approvals secured; long-lead items procured. - **Commercial Start:** **January 2026** - **ROCE Expectation:** **15–17%** annually - **Demand Outlook:** TAN demand expected to grow at **8–10% CAGR (FY22–FY30)** in coal, mining, and infrastructure sectors. > **Note:** Initial timeline (Aug 2024) suggested October 2025, but later updates shifted start to January 2026, likely due to operational optimization. --- ### **Innovation & Sustainability Initiatives** #### **CFCL-TERI Centre of Excellence** - **Partnership with The Energy and Resources Institute (TERI)**, funded by CFCL for 5 years. - **Goals:** Develop sustainable alternatives to chemical inputs — nano-fertilizers, biopesticides, mycorrhizal fungi, bio-stimulants. - **IP Rights:** Joint development with **exclusive global commercial rights** held by CFCL. - Focus on **high-value crops** (fruits, vegetables, niche crops) and **soil health improvement**. #### **Strategic Alliances & Sourcing** - Marketing partnerships with **innovator firms in Japan, US, Europe, and the Middle East** for access to advanced chemistries. - **P2P (Partner-to-Partner)** sourcing agreements with global suppliers for off-patent generics. - Collaborations with **Gen 1X** and other patented product innovators. #### **R&D Pipeline** - Focused on **nano-biotechnology, microbial solutions, and biogenic molecules**. - Pipeline includes **water-soluble fertilizers**, **biostimulants**, and next-gen **formulation delivery systems**. - Aiming for **₹300–400 crore in biologicals sales** over the medium term, with **commercial product launches expected between 2026–2029**. --- ### **Distribution & Farmer Engagement** #### **Seed to Harvest (S2H) Program** - Flagship farmer engagement model combining **digital + physical outreach**: - **Digital platforms** and social media marketing - Over **3,800 farmer meetings**, **3,000 field demos**, and **4 soil sampling days** (2,000+ samples collected) - Total of **58,000 soil samples analyzed** for precision farming recommendations - “**Hello Uttam**” helpline resolved **10,000+ queries** on dosage, pests, and crop care - Reaches over **230,000 farmers annually** and supports **brand loyalty and education**. #### **Market Penetration Goals (FY2026–27)** - Target **25% market width (~₹10,500 crore)** and **17% market depth (~₹1,750 crore)** in CPC/SN segments. - Expansion into **fruits, vegetables, and high-value crops** is central to the strategy. --- ### **Subsidiaries & Joint Ventures** - **Subsidiaries:** - CFCL Ventures Limited - Chambal Infrastructure Ventures Limited - ISGN Corporation - ISG Novasoft Technologies Limited - **Joint Venture:** - **Indo Maroc Phosphore S.A. (IMACID)** – Produces phosphoric acid and fertilizers. - **Production:** 525,000 tons (up from 435,000) - **Sales:** 435,000 tons (up from 380,000) - Benefited from lower input costs in FY25. --- ### **Financial & Operational Highlights** - **Revenue Drivers:** - Strong demand across **urea, NPK, CPC, and SN** segments - Geographic expansion, especially in **NPK-reliant southern states** - **Liquidity:** ~**60–65% of sales are cash-based**, supporting strong working capital position. - **Growth Strategy:** - Expand **non-subsidized fertilizer business** (CPC, SN, biologicals) to reduce dependency on government subsidies. - Scale high-margin, sustainable product categories.